Winton Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,648
| Closed | -$53K | – | 1515 |
|
|
2021
Q2 | $53K | Buy |
12,648
+549
| +5% | +$2.3K | ﹤0.01% | 1401 |
|
|
2021
Q1 | $60K | Buy |
+12,099
| New | +$60K | ﹤0.01% | 1348 |
|
|
2020
Q4 | – | Sell |
-31,506
| Closed | -$309K | – | 1570 |
|
|
2020
Q3 | $309K | Sell |
31,506
-28,007
| -47% | -$275K | 0.01% | 1237 |
|
|
2020
Q2 | $592K | Sell |
59,513
-1,132
| -2% | -$11.3K | 0.02% | 1150 |
|
|
2020
Q1 | $536K | Sell |
60,645
-28,057
| -32% | -$248K | 0.01% | 1009 |
|
|
2019
Q4 | $818K | Buy |
88,702
+61,327
| +224% | +$566K | 0.01% | 1113 |
|
|
2019
Q3 | $161K | Buy |
+27,375
| New | +$161K | ﹤0.01% | 1422 |
|